Health Care • Managed Health Care, Medicare Advantage & Optum Services • SIC 6324
$406.97 ▼ -3.94
(-0.96%)
MKT CAP: $368.83B • VOL: 4.30M
52W L $235 52W H $631
CONSENSUS RATING DISTRIBUTION (32 DESKS)
BUY: 27 HOLD: 5
SELL: 0
12M STREET TARGET RANGE
IMPLIED: +20.7%
LOW
$433
MEDIAN
$494
MEAN
$491
HIGH
$533
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
73/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE UNH TAPE
UNH // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
2026-11-01
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Jefferies Akash Tewari | UPGRADE | STRONG BUY | $487.93 | $444.02 | 2026-03-27 | $259.02 | +57.1% | 96% | A+ |
| Barclays Carter Gould / Andrew Mok | REITERATE | BUY | $432.58 | $393.65 | 2026-02-27 | $293.27 | +38.8% | 96% | A+ |
| UBS AJ Rice | TARGET REV | OUTPERFORM | $465.14 | $423.28 | 2026-04-24 | $354.92 | +14.7% | 77% | B |
| Morgan Stanley Terence Flynn | UPGRADE | STRONG BUY | $505.83 | $460.31 | 2026-09-11 | $379.09 | +7.3% | 70% | B |
| Citigroup Peter Verdult | UPGRADE | STRONG BUY | $487.11 | $443.27 | 2026-05-22 | $388.47 | +4.8% | 70% | B |
| Bernstein SocGen Group Courtney Breen / Lance Wilkes | REITERATE | OUTPERFORM | $473.28 | $430.68 | 2026-06-18 | $400.96 | +1.5% | 65% | C |
| Bank of America Securities Tim Anderson / Kevin Fischbeck | UPGRADE | STRONG BUY | $532.69 | $484.75 | 2026-08-28 | $392.95 | +3.6% | 65% | C |
| Goldman Sachs Chris Shibutani | UPGRADE | STRONG BUY | $517.23 | $470.68 | 2026-08-14 | $401.73 | +1.3% | 64% | C |
| Evercore ISI Umer Raffat | REITERATE | STRONG BUY | $509.90 | $545.59 | 2026-07-31 | $414.40 | -1.8% | 63% | C |
| J.P. Morgan Chris Schott / Lisa Gill | REITERATE | STRONG BUY | $500.95 | $536.02 | 2026-07-17 | $426.09 | -4.5% | 59% | C |